Advertisement

Topics

Latest "Steve Cardinalli" News Stories

10:51 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Steve Cardinalli" found in our extensive news archives from over 250 global news sources.

More Information about Steve Cardinalli on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Steve Cardinalli for you to read. Along with our medical data and news we also list Steve Cardinalli Clinical Trials, which are updated daily. BioPortfolio also has a large database of Steve Cardinalli Companies for you to search.

Showing "Steve Cardinalli" News Articles 1–25 of 451

Tuesday 13th November 2018

Simple Habit Raises $10 Million in Series A Funding, Expands Into Full-Service Daily Stress Relief Platform

Simple Habit, the leading daily stress relief platform for busy people, announced today that it has raised $10 million in Series A funding. This round of funding was led by Foundation Capital, the Silicon Valley-based venture capital firm, and headed by general partner Steve Vassallo. Simple Habit previously raised $2.8 million from seed investors, bringin...


LeanTaaS Secures $15 Million in Series C Investment to Accelerate Growth of Its Healthcare Operations Platform

Predictive Analytics and Machine Learning Technology Lowers Wait Times, Increases Patient Access, and Transforms Operational Performance LeanTaaS, Inc., a Silicon Valley predictive analytics and machine learning company that specializes in improving healthcare operations, today announced it has closed a $15 million Series C round of financing led by ...

Masy BioServices Leases 60,000 SF at Pepperell Place

Continued Growth Creates Need for More Biostorage Space PEPPERELL, Mass. (PRWEB) November 13, 2018 In one of the biggest commercial leases in the Nashoba region this year, Masy BioServices, the largest employer in Pepperell, Mass., has increased its leased space at Pepperell Place to 60,000 square feet. The 35 year old company operates two other locations in town plus a facility in Pennsylvania. ...


FDA Grants DeNovo Clearance to Atlantic Therapeutics for INNOVO® Therapy Device to Treat Stress Urinary Incontinence

INNOVO® is the first ever transcutaneous electrical stimulator cleared by the FDA, offering US women a safe, clinically effective and non-invasive choice to treat stress urinary incontinence In its pivotal multi-centre randomized controlled clinical trial, 87.2% of INNOVO® users were dry or mild after a 12-week treatment p...

Monday 12th November 2018

Australians growing more aware of antibiotic resistance

As part of World Antibiotic Awareness Week (12–18 November 2018), not-for-profit organisation NPS MedicineWise has released new research into antibiotic resistance in Australia — and the results are a mixed bag of good news and bad news. As explained by NPS MedicineWise CEO Steve Morris, the high use of antibiotics in Australia is increasing the risk of antibiotic resistance. This occurs when...

International Cannabrands Inc.: International Cannabrands CEO Steve Gormley Provides Letter to Shareholders

CALGARY, AB / ACCESSWIRE / November 12, 2018 / International Cannabrands Inc. (CSE: JUJU) (the "Company") shared CEO Steve Gormley's letter to Shareholders. Dear Shareholders, It has been a little ...

Saturday 10th November 2018

Cardiva Medical Announces Positive Results of the AMBULATE Pivotal Study Evaluating the VASCADE MVP System Compared to Manual Compression for Multi-Vessel Closure Following Electrophysiology Procedures

The AMBULATE pivotal study met its primary efficacy endpoint. The median time to patients getting on their feet following arrhythmia ablation procedures was reduced by 3.9 hours. AMBULATE demonstrated that patients in the VASCADE MVP arm had significantly improved patient satisfaction and a significant reduction in the post-...

Aerpio Pharmaceuticals' (ARPO) CEO Steve Hoffman on Q3 2018 Results - Earnings Call Transcript

Friday 9th November 2018

China Jo-Jo Drugstores Appoints Mr. Wei Hu as COO to Strengthen Operations for Future

HANGZHOU, China, Nov. 9, 2018 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, today announced that Mr. Wei Hu was nominated and approved by the Company's Board of Directors to serve...

Obsidian Presents Preclinical Data Demonstrating Precise Regulation of Cytokines and CAR in T cells with Destabilizing Domain Technology using FDA-Approved Drugs

Data presented at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting Obsidian Therapeutics, Inc., a biotechnology company developing cell therapies with pharmacologic operating systems, today announced the presentation of preclinical data demonstrating fine-tuned regulation of cytokine production and CAR-T function using Destabilizi...

Thursday 8th November 2018

Synthetic Biologics Inc. (SYN) CEO Steve Shallcross on Q3 2018 Results - Earnings Call Transcript

DNA Script Creates U.S. Subsidiary and Expands Executive Team in the U.S.

Company creates U.S. subsidiary and adds Dr. Jeffrey Jeddeloh as VP of Business Development, Commercial Strategy, Dr. Stephen Macevicz as VP of IP and Dr. Christine Peponnet as VP of Technology Development. DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced the creation of DNA Script Inc., its U.S. subsidiary. ...

Maine Family Raises Over $5,000 for the Dempsey Center to Support Cancer Research Through CLYNK Bottle and Can Redemption

Local Businesses and Volunteers Rally and Recycle for a Cause SOUTH PORTLAND, Maine (PRWEB) November 08, 2018 CLYNK (Count and Crush, LLC), a national leader in bottle redemption and recycling services, annually helps support Cans for a Cure. Q97.9, Townsquare Media, Inc., launched the Cans for a Cure charity bottle drive over a decade ago. This year, donors from across the state raised a grand t...

Wednesday 7th November 2018

ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on Q3 2018 Results - Earnings Call Transcript

Steve Ferrara loses race to become first radiologist elected to Congress

The interventional radiologist, and former chief medical officer for the U.S. Navy, Steve Ferrara, MD, lost to his Democratic challenger and former Phoenix Mayor, Greg Stanton in the race to represent Arizona’s 9th Congressional District, according to an ArizonaCentral report.

Pieris Pharmaceuticals' (PIRS) CEO Steve Yoder on Q3 2018 Results - Earnings Call Transcript

Erchonia & InnerScope Hearing Technologies to Conduct FDA Clinical Trial to Treat Tinnitus with Low Level Laser Technology

Erchonia Corporation today announces a joint development agreement with InnerScope Hearing Technologies to conduct clinical research and trials for the purpose of obtaining 510(k) clearances from the FDA for 3LT devices to treat hearing-related conditions, including tinnitus. MELBOURNE, Fla. (PRWEB) November 07, 2018 Erchonia Corporation, the global leader in the manufacturing and development of ...

The @PistoiaAlliance’s Sir Alasdair Breckenridge and Steve Arlington have spoken about the drastic impact #Brexit could have on #science projects with @Pharmafocus. You can read what they had to say here: https://bit.ly/2REbNDo 

The @PistoiaAlliance’s Sir Alasdair Breckenridge and Steve Arlington have spoken about the drastic impact #Brexit could have on #science projects with @Pharmafocus. You can read what they had to say here: https://bit.ly/2REbNDo 

Tuesday 6th November 2018

UNC REX Named One of the Nation’s Top 50 Cardiovascular Hospitals by IBM Watson Health

Recognition based on factors such as mortality, complications, readmissions and cost UNC REX Healthcare has been named to a list of the nation’s 50 best Cardiovascular Hospitals by IBM Watson Health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181106005874/en/

Monday 5th November 2018

Cardiva Medical to Present New Clinical Data on the VASCADE MVP System for Multi-Vessel Closure Following Electrophysiology Procedures

Late-Breaking Abstract to be Presented at American Heart Association Scientific Sessions 2018 Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that new data from the randomized AMBULATE study will be presented in a late-breaking session on new trials in cardiovascular care at Scientific Sessions 2018, the annual med...

Intact Vascular Hires Industry Veteran Steve MacKinnon as Vice President of Sales

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Steve MacKinnon has joined its senior management team as Vice President of Sales, effective immediately. Reporting to the CEO, Mr. MacKinnon will oversee the creation of a U.S. based sales team and will play a central role in pl...

Friday 2nd November 2018

Hilliard Martinez Gonzales: Lawyers For Border Victim Tell Trump That Ordering The Shooting Of ...

CORPUS CHRISTI, Texas, Nov. 2, 2018 /PRNewswire/ -- Today, Bob Hilliard and Steve Shadowen have responded to President Trump's recent comments that rocks thrown should Read more...

MAC Clinical Research Expands its Global Site Network and Access to Patients in Australia and Asia Pacific Regions

Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient numbers and to conduct their study to the highest quality possible. Every sponsor faces the same problems, these being the lack of high performing sites available, with eligible patients to power studies forward, leading to study delays, unforeseen and extra st...

Breakthrough in Rapid Diagnostic for Antimicrobial Resistance

DNAe achieves major milestone in a novel clinical sequencing platform, successfully completing the first phase of its $51.9 million contract with US government’s BARDA London, UK and Carlsbad, CA, USA – 2 November 2018 – A rapid new diagnostic platform that harnesses the power of semiconductor DNA sequencing, promises to revolutionise the ability of physicians to treat antimi...

Conatus Pharmaceuticals - Q3-2018 - Phase 3 Clinical Results Arriving Soon

On Thursday, November 1, 2018, Conatus Pharmaceuticals (CNAT) announced its results for Q3-2018 and held a conference call, and filed its quarterly report with the SEC. The company is poised to release its next Phase 3 clinical results before year-end.  


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks